Zogenix, Inc.’s (ZGNX) Migraine Treatment Receives Top Ranking as Most Innovative Life Sciences Product
Zogenix, Inc., a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced that CONNECT, a regional San Diego nonprofit organization, has selected Zogenix’s migrane treatment SUMAVEL(R) DosePro™ Needle-free Delivery System as a 2010 Most Innovative Product (MIP) winner. The 2010 CONNECT MIP Awards recognize emerging technologies and cutting-edge products that drive San Diego's innovation economy. SUMAVEL DosePro was awarded top ranking as the most innovative product for 2010 in the Life Sciences -- Medical Products category. SUMAVEL DosePro is a needle-free, quick response treatment for migraine attacks. The treatment is the…